Pathways
COVID-19-associated Guillain-Barre Syndrome
Description:
Coronavirus disease 2019 (COVID-19), the disease caused by the beta coronavirus SARS-CoV-2 was believed to be restricted to the respiratory system since its outbreak in January 2020. Later it was found that it also involves multiple other organs including the central and peripheral nervous system. Neurological problems like ischemic, hemorrhagic strokes, venous sinus thrombosis, encephalopathy, cerebral hemorrhage, encephalitis, and neurodegenerative diseases like Guillain–Barre syndrome (GBS) has been found to be assoc...
References:
-
COVID-19-Associated Guillain-Barre Syndrome: Atypical Para-infectious Profile, Symptom Overlap, and Increased Risk of Severe Neurological Complications.
SN Compr Clin Med. 2020 Nov 21:1-13. doi: 10.1007/s42399-020-00646-w. Epub ahead of print. -
Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome.
J Neuroimmune Pharmacol. 2021 Mar;16(1):48-58. doi: 10.1007/s11481-020-09980-1. Epub 2021 Jan 18. -
Neurologic complications of COVID-19.
Cleve Clin J Med. 2020 Nov 23;87(12):729-734. doi: 10.3949/ccjm.87a.ccc058. -
Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.
J Neurol. 2021 Apr;268(4):1133-1170. doi: 10.1007/s00415-020-10124-x. Epub 2020 Aug 25.
You can view details of this pathway by subscribing:
9853 Pacific Heights Blvd.
Suite D., San Diego, CA 92121, USA
Tel: 858-224-2869
Fax: 858-205-1192
info@proteinlounge.com
Databases
Tools
Institutional License
Need our databases and tools to be availed by your whole university or institute? We recommend signing up for our Site License.
To set up a license, please contact: info@proteinlounge.com
Copyright © Protein Lounge Inc.
Terms & Conditions